Cytokine storms: understanding COVID-19

Mangalmurti, Nilam, Hunter, Christopher A.·2020·Immunity

Cited by (703)

Items 201–300 of 703

  1. Neurological Consequences, Mental Health, Physical Care, and Appropriate Nutrition in Long-COVID-19
    Pasquale Picone, Tiziana Sanfilippo, Rossella Guggino, Luca Scalisi, Roberto Monastero, Roberta Baschi, Valeria Mandalà, Livio San Biagio, Manfredi Rizzo, Daniela Giacomazza et al. · 2022 · Cellular and Molecular Neurobiology
  2. During Sepsis and COVID-19, the Pro-Inflammatory and Anti-Inflammatory Responses Are Concomitant
    Jean‐Marc Cavaillon · 2023 · Clinical Reviews in Allergy & Immunology
  3. Unravelling the broader complexity of IL-6 involvement in health and disease
    Robert L. Jenkins, Stuart T. O. Hughes, Ana Cardus Figueras, Simon A. Jones · 2021 · Cytokine
  4. An Overview of Systematic Reviews of the Role of Vitamin D on Inflammation in Patients with Diabetes and the Potentiality of Its Application on Diabetic Patients with COVID-19
    Christiano Argano, Raffaella Mallaci Bocchio, Marika Lo Monaco, Salvatore Scibetta, Giuseppe Natoli, Attilio Cavezzi, Emidio Troiani, Salvatore Corrao · 2022 · International Journal of Molecular Sciences
  5. Ultrafiltration isolation, structure and effects on H1N1-induced acute lung injury of a heteropolysaccharide from Houttuynia cordata
    Lishuang Zhou, Yukun Jiao, Jiayue Tang, Zhizhi Zhao, Haiyan Zhu, Yan Lu, Daofeng Chen · 2022 · International Journal of Biological Macromolecules
  6. Prognostic value of inflammatory markers in patients with COVID-19 in Indonesia
    Ignatius Bima Prasetya, Cucunawangsih Cucunawangsih, Jane Olivia Lorens, Veli Sungono, Korri Elvanita El-Khobar, Ratna Sari Wijaya · 2021 · Clinical Epidemiology and Global Health
  7. Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19
    Cédric Garcia, Jonathan Au Duong, Michaël Poette, Agnès Maurel Ribes, Bruno Payré, Vincent Mémier, Piérre Siè, Vincent Minville, Sophie Voisin, Bernard Payrastre et al. · 2022 · Blood Advances
  8. Mindfulness Meditation Interventions for Long COVID: Biobehavioral Gene Expression and Neuroimmune Functioning
    Nicole Porter, Leonard A. Jason · 2022 · Neuropsychiatric Disease and Treatment
  9. TRIM21 promotes ubiquitination of SARS‐CoV‐2 nucleocapsid protein to regulate innate immunity
    Shenglan Mao, Xue-Fei Cai, Siqiang Niu, Jie Wei, Ning Jiang, Haijun Deng, Wen Wang, Jing Zhang, Shimei Shen, Yuanyan Ma et al. · 2023 · Journal of Medical Virology
  10. Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology
    Man Wang, Fei Yu, Wenguang Chang, Yuan Zhang, Lei Zhang, Peifeng Li · 2023 · Frontiers in Immunology
  11. A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations
    Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, Rene Bernadette Khan, Hezekiel Mathambo Kumalo · 2023 · COVID
  12. Electrophysiological features of acute inflammatory demyelinating polyneuropathy associated with SARS-CoV-2 infection
    Antonino Uncini, Camillo Foresti, Barbara Frigeni, Benedetta Storti, Maria Cristina Servalli, Stefano Gazzina, Giuseppe Cosentino, Francesca Bianchi, Ubaldo Del Carro, Enrico Alfonsi et al. · 2021 · Neurophysiologie Clinique
  13. Immunometabolic bases of type 2 diabetes in the severity of COVID-19
    Rebeca Viurcos-Sanabria, Galileo Escobedo · 2021 · World Journal of Diabetes
  14. 2‐Deoxy‐ d ‐glucose induces deglycosylation of proinflammatory cytokine receptors and strongly reduces immunological responses in mouse models of inflammation
    Ikuno Uehara, Mitsuko Kajita, Atsuko Tanimura, Shigeaki Hida, Munehiko Onda, Zenya Naito, Shinsuke Taki, Nobuyuki Tanaka · 2022 · Pharmacology Research & Perspectives
  15. Effects and Causes of Detraining in Athletes Due to COVID-19: A Review
    Alfredo Córdova, Alberto Caballero-García, Enrique Roche, Daniel Pérez-Valdecantos, David Cesar Noriega · 2022 · International Journal of Environmental Research and Public Health
  16. Mouse models in COVID-19 research: analyzing the adaptive immune response
    S. Clever, A. Volz · 2022 · Medical Microbiology and Immmunology
  17. Role of mast cells in the pathogenesis of severe lung damage in COVID-19 patients
    Andrey Valerievich Budnevsky, Sergey Nikolaevich Avdeev, Djuro Kosanovic, В. В. Шишкина, Andrey A. Filin, Dmitry I. Esaulenko, Е. S. Ovsyannikov, Т. В. Самойленко, А Н Редькин, Olga Suvorova et al. · 2022 · Respiratory Research
  18. Comparison of VEGF‐A values between pregnant women with COVID‐19 and healthy pregnancies and its association with composite adverse outcomes
    Nuray Yazıhan, Atakan Tanaçan, Seyit Ahmet Erol, Ali Taner Anuk, Selcan Sınacı, Derya Biriken, Hüseyin Levent Keskin, Ozlem T. Moraloglu, Dilek Şahın · 2020 · Journal of Medical Virology
  19. Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation for severe ARDS
    Lauren Raff, Trista D S Reid, Daniel J. Johnson, Evan J. Raff, Andrew Schneider, Anthony Gbolahan Charles, Jared Robert Gallaher · 2021 · The American Journal of Surgery
  20. Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study
    Thaís Garcias Moreira, Kimble Teixeira Fonseca Matos, Giovana S. De Paula, Thais M. M. Santana, Raquel G. Da Mata, Fernando C. Pansera, André Sementilli Cortina, Marcelle G. Spinola, Clare Baecher‐Allan, Gerson Dierley Keppeke et al. · 2021 · Frontiers in Immunology
  21. Enhanced Label-Free Nanoplasmonic Cytokine Detection in SARS-CoV-2 Induced Inflammation Using Rationally Designed Peptide Aptamer
    Jiacheng He, Lang Zhou, Gangtong Huang, Jialiang Shen, Wu Chen, Chuanyu Wang, Albert Kim, Zhuoyu Zhang, Weiqiang Chen, Siyuan Dai et al. · 2022 · ACS Applied Materials & Interfaces
  22. Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2–infected individuals reveal unlinked immune signatures
    Supriya Ravichandran, Gabrielle Grubbs, Juanjie Tang, Youri Lee, Chang Huang, Hana Golding, Surender Khurana · 2021 · Science Advances
  23. Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis
    Yanni Lai, Tiantian Han, Zizhao Lao, Geng Li, Jianyong Xiao, Xiaohong Liu · 2021 · Frontiers in Pharmacology
  24. HLJ1 amplifies endotoxin-induced sepsis severity by promoting IL-12 heterodimerization in macrophages
    Weijia Luo, Sung‐Liang Yu, Chia‐Ching Chang, Min-Hui Chien, Ya‐Ling Chang, Keng-Mao Liao, Pei-Chun Lin, Kuei‐Pin Chung, Ya‐Hui Chuang, Jeremy J.W. Chen et al. · 2022 · eLife
  25. COVID-19 alters human microbiomes: a meta-analysis
    Rine Christopher Reuben, Rémy Beugnon, Stephanie D. Jurburg · 2023 · Frontiers in Cellular and Infection Microbiology
  26. Generating prophylactic immunity against arboviruses in vertebrates and invertebrates
    Daniel J. Rawle, Leon E. Hugo, Abigail L. Cox, Gregor J. Devine, Andreas Suhrbier · 2024 · Nature reviews. Immunology
  27. Extracellular Vesicle‐Inspired Therapeutic Strategies for the COVID‐19
    Ziwei Hu, Wei Wang, Ying Lin, Hui Guo, Yiwen Chen, Junjie Wang, Feng Yu, Lang Rao, Zhijin Fan · 2024 · Advanced Healthcare Materials
  28. Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
    Esther Silberberg, János G. Filep, Amiram Ariel · 2022 · Frontiers in Immunology
  29. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes
    Stephanie S. Cabler, Anthony R. French, Anthony Orvedahl · 2020 · Trends in Molecular Medicine
  30. Animal Models of COVID-19 II. Comparative Immunology
    R. Veenhuis, C. Zeiss · 2021 · ILAR journal
  31. Prior immunosuppressive therapy is associated with mortality in COVID‐19 patients: A retrospective study of 835 patients
    Elliot H. Akama‐Garren, Jonathan X. Li · 2021 · Journal of Medical Virology
  32. The Antiviral Roles of Hydrogen Sulfide by Blocking the Interaction between SARS‐CoV‐2 and Its Potential Cell Surface Receptors
    Jing Dai, Xu Teng, Sheng Jin, Yuming Wu · 2021 · Oxidative Medicine and Cellular Longevity
  33. Society for Maternal-Fetal Medicine Special Statement: COVID-19 research in pregnancy: progress and potential
    Rupsa C. Boelig, Kjersti Marie Aagaard, Michelle Precourt Debbink, Alireza Abdollah Shamshirsaz · 2021 · American Journal of Obstetrics and Gynecology
  34. Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve?
    Nadia Μ. Hamdy, Fatma H. Shaker, Xianquan Zhan, Emad B. Basalious · 2022 · The EPMA Journal
  35. Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
    Daniela Latorre · 2022 · European Journal of Immunology
  36. Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection
    Anthony Nuber‐Champier, Alexandre Cionca, Gautier Bréville, Philippe Voruz, Isabele Jacot de Alcântara, Gilles Allali, Patrice H. Lalive, Lamyae Benzakour, Karl‐Olof Lövblad, Olivia Braillard et al. · 2023 · Psychoneuroendocrinology
  37. Brefeldin A and kifunensine modulate LPS-induced lung endothelial hyperpermeability in human and bovine cells
    Khadeja‐Tul Kubra, Nektarios Barabutis · 2021 · American Journal of Physiology-Cell Physiology
  38. Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT)
    Mareev VIu, Yа. A. Orlova, Е.П. Павликова, Zhanna Alekseevna Akopyan, С.Т. Мацкеплишвили, Плисюк Алина Геннадьевна, Elena M. Seredenina, A. V. Potapenko, П. С. Малахов, Larisa Mikhailovna Samokhodskaya et al. · 2020 · Kardiologiia
  39. COVID–19 infection and stroke risk
    Shaghayegh Sadeghmousavi, Nima Rezaei · 2020 · Reviews in the Neurosciences
  40. Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic data
    Zehua Dong, Qiyu Yan, Wenxiu Cao, Zhixian Liu, Xiaosheng Wang · 2022 · Frontiers in Immunology
  41. ZBTB7A promotes virus-host homeostasis during human coronavirus 229E infection
    Xinyu Zhu, Joseph D. Trimarco, Courtney A. Williams, Alejandro Barrera, Timothy E. Reddy, Nicholas S. Heaton · 2022 · Cell Reports
  42. Discovery of the key active compounds in Citri Reticulatae Pericarpium (Citrus reticulata “Chachi”) and their therapeutic potential for the treatment of COVID-19 based on comparative metabolomics and network pharmacology
    Fu Wang, Lin Chen, Hongping Chen, Zhuyun Yan, Youping Liu · 2022 · Frontiers in Pharmacology
  43. Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
    Yiying Xue, Husheng Mei, Yisa Chen, James D. Griffin, Qingsong Liu, Ellen Weisberg, Jing Chun Yang · 2023 · MedComm
  44. siRNA Nanoparticle Dry Powder Formulation with High Transfection Efficiency and Pulmonary Deposition for Acute Lung Injury Treatment
    Rui Li Xu, Chenjie Xia, Xiongxiong He, Changhui Hu, Yinjia Li, Yufeng Zhang, Zhipeng Chen · 2024 · ACS Applied Materials & Interfaces
  45. Inflammatory endotypes of CRSwNP and responses to COVID-19
    Ming Wang, Chengshuo Wang, Luo Zhang · 2020 · Current Opinion in Allergy and Clinical Immunology
  46. The CXCL8/MAPK/hnRNP-K axis enables susceptibility to infection by EV-D68, rhinovirus, and influenza virus in vitro
    Qingran Yang, Haoran Guo, Huili Li, Zhaoxue Li, Fushun Ni, Zhongmei Wen, Kai Liu, Huihui Kong, Wei Wei · 2025 · Nature Communications
  47. Protective effects elicited by cow milk fermented with L. Paracasei CBAL74 against SARS-CoV-2 infection in human enterocytes
    Lorella Paparo, Cristina Bruno, Veronica Ferrucci, Erika Punto, Maurizio Viscardi, Giovanna Fusco, Pellegrino Cerino, Alessia Romano, Massimo Zollo, Roberto Berni Canani · 2021 · Journal of Functional Foods
  48. Sex-dependent immune response and lethality of COVID-19
    Albert Jiarui Li, Xiajun Li · 2020 · Stem Cell Research
  49. Immunoregulatory therapy strategies that target cytokine storms in patients with COVID‑19 (Review)
    Xianyao Wang, Zhixu He, Xing Zhao · 2021 · Experimental and Therapeutic Medicine
  50. SARS‐CoV‐2 sculpts the immune system to induce sustained virus‐specific naïve‐like and memory B‐cell responses
    Leire de Campos‐Mata, Sonia Tejedor Vaquero, Roser Tachó‐Piñot, Janet Piñero, Emilie K. Grasset, Itziar Arrieta‐Aldea, Natalia Rodrigo Melero, Carlo Carolis, Juan Pablo Horcajada, Andrea Cerutti et al. · 2021 · Clinical & Translational Immunology
  51. Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection
    MUHAMMAD BILAL LATIF, Sudhanshu Shukla, Perla M. Del Río Estrada, Susan Pereira Ribeiro, Rafick‐Pierre Sékaly, Ashish Sharma · 2021 · Translational research
  52. COVID-19 in cancer patients
    Suranjith Luke Seneviratne, Widuranga Wijerathne, Pamodh Chanuka Yasawardene, Buddhika Somawardana · 2022 · Transactions of the Royal Society of Tropical Medicine and Hygiene
  53. Clinical characteristics and mortality associated with COVID-19 at high altitude: a cohort of 5161 patients in Bogotá, Colombia
    David René Rodríguez Lima, Ángela María Pinzón-Rondón, Cristhian Rubio Ramos, Darío Isaías Pinilla Rojas, María José Niño-Orrego, Mateo Andrés Díaz Quiroz, Nicolás Molano‐González, Jorge Enrique Ceballos Quintero, Alex Francisco Arroyo Santos, Ángela María Ruiz-Sternberg · 2022 · International Journal of Emergency Medicine
  54. Liposome encapsulated clodronate mediated elimination of pathogenic macrophages and microglia: A promising pharmacological regime to defuse cytokine storm in COVID-19
    Sowbarnika Ravichandran, Nivethitha Manickam, Mahesh Kandasamy · 2022 · Medicine in Drug Discovery
  55. The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors
    Mengqi Xiang, Xiaoming Wu, Haijiao Jing, Langjiao Liu, Chunxu Wang, Yufeng Wang, Valerie Anne Novakovic, Jialan Shi · 2022 · Frontiers in Immunology
  56. Analysis of Protein Biomarkers From Hospitalized COVID-19 Patients Reveals Severity-Specific Signatures and Two Distinct Latent Profiles With Differential Responses to Corticosteroids*
    Philip A. Verhoef, Alexandra B. Spicer, Carlos G. Lopez-Espina, Akhil Bhargava, Lee Schmalz, Matthew D. Sims, Ashok V. Palagiri, Karthik Iyer, Matthew J. Crisp, Alexandra Halalau et al. · 2023 · Critical Care Medicine
  57. Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients
    Sajid Mansoor, Ayesha Raza Butt, Asima Bibi, Saima Mushtaq, Inayat Ullah, Fahad Alshahrani, Amjad Khan, Atika Mansoor · 2023 · PLoS ONE
  58. The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2–Infected Individuals with Severe Disease
    Suguru Saito, Najmeh Bozorgmehr, Wendy Sligl, Mohammed Osman, Shokrollah Elahi · 2024 · The Journal of Immunology
  59. Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients
    Debby A.J. van Riel, Carmen W.E. Embregts, Gregorius J. Sips, Johannes P. C. van den Akker, Henrik Endeman, Els van Nood, Matthijs P. Raadsen, Lisa Bauer, Jeroen J. A. van Kampen, Richard Molenkamp et al. · 2021 · mSphere
  60. Diabetes and susceptibility to infections: Implication for COVID‐19
    Gustav van Niekerk, Michelle van der Merwe, Anna‐Mart Engelbrecht · 2021 · Immunology
  61. Induction of the NEK family of kinases in the lungs of mice subjected to cecal ligation and puncture model of sepsis
    Mohammad Afaz Uddin, Mohammad Shohel Akhter, Khadeja‐Tul Kubra, Nektarios Barabutis · 2021 · Tissue Barriers
  62. The Associations between Cytokine Levels, Kidney and Heart Function Biomarkers, and Expression Levels of Angiotensin-Converting Enzyme-2 and Neuropilin-1 in COVID-19 Patients
    Rabab Hussain Sultan, Maged Abdallah, Tarek Mohamed Ali, Amr E. Ahmed, Hebatallah Hany Assal, Basem Hassan Elesawy, Osama M. Ahmed · 2022 · Vaccines
  63. CD8 + T cells mediate antiviral response in severe fever with thrombocytopenia syndrome
    Lu Zong, Fan Yang, Siyu Liu, Yufeng Gao, Fang Xia, Meijuan Zheng, Yuanhong Xu · 2022 · The FASEB Journal
  64. Plant-Derived Food Grade Substances (PDFGS) Active Against Respiratory Viruses: A Systematic Review of Non-clinical Studies
    Francis Uchenna Umeoguaju, Benson Chukwunweike Ephraim-Emmanuel, Kingsley Chukwuemeka Patrick-Iwuanyanwu, Judith Terry Zelikoff, Orish Ebere Orisakwe · 2021 · Frontiers in Nutrition
  65. Immunomodulating Phytochemicals: An Insight into their Potential Use in Cytokine Storm Situations.
    Abdusalam Abdullah Alarabei, Nur Aimi Liyana Abd Aziz, Nur Izah Ab Razak, Razif Abas, Hasnah Bahari, Maizaton Atmadini Abdullah, Mohd Khairi Hussain, Amin Malik Shah Abdul Majid, Rusliza Basir · 2023 · Advanced Pharmaceutical Bulletin
  66. Viral myocarditis: From molecular mechanisms to therapeutic prospects
    Han-Wei Yan, Ying-Da Feng, Na Tang, Feng-Chuan Cao, Yingfeng Lei, Wei Cao, Xiaoqiang Li · 2024 · European Journal of Pharmacology
  67. Coronavirus Desease 2019 (COVID-19) in Children: Lessons from Pediatric Rheumatology
    Maria I. Kaleda, И. П. Никишина, E. S. Fedorov, Evgeny Lvovich Nasonov · 2020 · Rheumatology Science and Practice
  68. Calming the inflammatory storm in severe COVID-19 infections: Role of biologics- A narrative review
    David Banji, Saad S. Alqahtani, Otilia J.F. Banji, Shamna Machanchery, Ambreen Shoaib · 2021 · Saudi Pharmaceutical Journal
  69. Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability
    Mariana Guilger‐Casagrande, Cecília Torqueti de Barros, Vitória A. N. Antunes, Daniele Ribeiro de Araújo, Renata de Lima · 2021 · Frontiers in Cellular and Infection Microbiology
  70. Peripheral Plasma Cells Associated with Mortality Benefit in Severe COVID-19: A Marker of Disease Resolution
    Mary Catherine Boulanger, Emily Molina, Kunbo Wang, Thomas S. Kickler, Yanxun Xu, Brian Thomas Garibaldi · 2021 · The American Journal of Medicine
  71. Italian association for the study of the liver position statement on SARS-CoV2 vaccination
    Francesco Paolo Russo, Salvatore Silvio Piano, Raffaele Bruno, Patrizia Burra, Massimo Puoti, Mario Masarone, Sara Montagnese, Francesca Romana Ponziani, Salvatore Petta, Alessio Aghemo · 2021 · Digestive and Liver Disease
  72. Metabolic reprogramming and immune regulation in viral diseases
    Goutham V. Ganesh, Kunka Mohanram Ramkumar · 2021 · Reviews in Medical Virology
  73. Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes
    Md. Babul Islam, Utpala Nanda Chowdhury, Zulkar Nain, Shahadat Uddin, Mohammad Boshir Ahmed, Mohammad Ali Moni · 2021 · Computers in Biology and Medicine
  74. Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm
    Paulina Niedźwiedzka‐Rystwej, Adam Majchrzak, Sara Kurkowska, Paulina Małkowska, Olga Sierawska, Rafał Hrynkiewicz, Miłosz Parczewski · 2022 · International Journal of Molecular Sciences
  75. Characteristics and outcome of critically ill patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to a tertiary care center in the United Arab Emirates during the first wave of the SARS-CoV-2 pandemic. A retrospective analysis
    Khaled Ismail, Hatim Bensasi, Ahmed Taha, Aamir Nazir, Mohamed Abdelkhalek, Walid A. Mohamed, Dipak Lodhe, Samuel Buschbeck, Michael W Bauer, Yasser L. Sakr · 2021 · PLoS ONE
  76. The des-Arg9-bradykinin/B1R axis: Hepatic damage in COVID-19
    Gabriel Moreira de M. Mendes, Israel Júnior Borges do Nascimento, Paulo HS. Marazzi-Diniz, Izabela Boueri da Silveira, Matheus F. Itaborahy, Luiz E. Viana, Filipe Alex da Silva, Monique Freire Santana, Rebecca Augusta de Araújo Pinto, Bruna Guimarães Dutra et al. · 2022 · Frontiers in Physiology
  77. Sea Cucumber and Blueberry Extracts Suppress Inflammation and Reduce Acute Lung Injury through the Regulation of NF-κB/MAPK/JNK Signaling Pathway in Lipopolysaccharide-Treated C57BL/6 Mice
    Oladapo Fisoye Fagbohun, Wasitha P. D. W. Thilakarathna, Juan Zhou, Christine Lehmann, Guangling Jiao, H.P. Vasantha Rupasinghe · 2024 · Molecules
  78. Covid-19 systemic infection exacerbates pre-existing acute disseminated encephalomyelitis (ADEM)
    Omar Hussein, Ahmed Abd Elazim, Michel Torbey · 2020 · Journal of Neuroimmunology
  79. Can BCG vaccine protect against COVID‐19 via trained immunity and tolerogenesis?
    Preetam Basak, Naresh Kumar Sachdeva, Devi Dayal · 2020 · BioEssays
  80. Analysis of Peripheral Blood IL-6 and Leukocyte Characteristics in 364 COVID-19 Patients of Wuhan
    Quan Li, Yuyu Xie, Zhangbo Cui, Shi Tang, Baodong Yuan, Hai Huang, Yanjie Hu, Yaling Wang, Ming Zhou, Chunwei Shi · 2020 · Frontiers in Immunology
  81. Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
    Brendan L. Thoms, Jeanne Gosselin, Bonita S. Libman, Benjamin Littenberg, Ralph C. Budd · 2022 · SN Comprehensive Clinical Medicine
  82. Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination
    Miriam Echaide, Ibone Labiano, Marina Delgado, Ángela Fernández de Lascoiti, Patricia Ochoa, Maider Garnica, Pablo Ramos, Luisa Chocarro, Leticia Fernández, Hugo Arasanz et al. · 2022 · Cancers
  83. Myeloid dysregulation and therapeutic intervention in COVID-19
    Runxia Gu, Tianyang Mao, Lu Qiao, Tina Tianjiao Su, Jun Wang · 2021 · Seminars in Immunology
  84. SARS‐CoV‐2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs
    Lieve E. H. van der Donk, Julia Eder, John L. van Hamme, Philip J. M. Brouwer, Mitch Brinkkemper, Ad C. van Nuenen, Marit J. van Gils, Rogier W. Sanders, Neeltje A. Kootstra, Marta Bermejo‐Jambrina et al. · 2022 · European Journal of Immunology
  85. Exocyst complex component 2 is a potential host factor for SARS-CoV-2 infection
    Renxing Yi, Rina Hashimoto, Ayaka Sakamoto, Yasufumi Matsumura, Miki Nagao, Kazutoshi Takahashi, Kazuo Takayama · 2022 · iScience
  86. CRISPR/Cas12a-based fluorescence aptasensor integrated with two-dimensional cobalt oxyhydroxide nanosheets for IFN-γ detection
    Dandan Ren, Qiutong Chen, Xinyi Xia, Guanhong Xu, Fangdi Wei, Jing Yang, Qin Hu, Yao Cen · 2023 · Analytica Chimica Acta
  87. SARS-CoV-2 nucleocapsid protein promotes TMAO-induced NLRP3 inflammasome activation by SCAP–SREBP signaling pathway
    Mi‐Hua Liu, Xiaolong Lin, Lele Xiao · 2023 · Tissue and Cell
  88. Luteolin Mitigates Acute Lung Injury Through Immune Modulation and Antinecroptosis Effects by Targeting the BTK and FLT3 Signaling Pathways
    Zhixing Cao, Huanan Rao, Wenya Yang, Xiaoxue Hu, Xin Kang, Daoyin Gong, Xiaominting Song, Yali Ren, Cheng Peng, Yuzhi Li et al. · 2025 · Journal of Agricultural and Food Chemistry
  89. Simple predictive models identify patients with COVID-19 pneumonia and poor prognosis
    Mar Riveiro‐Barciela, Moisés Labrador‐Horrillo, Laura Camps-Relats, Didac González-Sans, Meritxell Ventura Cots, María Terrones-Peinador, Andrea Núñez Conde, Mónica Martínez‐Gallo, Manuel Hernández-González, Andrés Antón et al. · 2020 · PLoS ONE
  90. Pulmonary Edema in COVID-19 Treated with Furosemide and Negative Fluid Balance (NEGBAL): A Different and Promising Approach
    Jose L. Francisco Santos, Patricio Zanardi, Veronica Alo, Marcelo Rodriguez, Federico Magdaleno, Virginia De Langhe, Vanina Dos Santos, Giuliana Murialdo, Andrea Villoldo, Micaela Coria et al. · 2021 · Journal of Clinical Medicine
  91. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm
    Abdullahi Rabiu Abubakar, Rahnuma Ahmad, Adekunle Babajide Rowaiye, Sayeeda Rahman, Katia Iskandar, Siddhartha Dutta, Angus Nnamdi Oli, Sameer Dhingra, Maryam Abba Tor, Ayukafangha Etando et al. · 2022 · Life
  92. Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients
    Nikolaos Gatselis, Vasiliki Lygoura, Aggeliki Lyberopoulou, George Giannoulis, Anna Samakidou, Antonia Vaiou, George Vatidis, Katerina M. Antoniou, Aggelos Stefos, Sarah P. Georgiadou et al. · 2022 · Viruses
  93. Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19
    Aparajita Sen, Arti Nigam, Meenakshi Vachher · 2022 · International Journal of Peptide Research and Therapeutics
  94. Does Neutrophil-to-lymphocyte Ratio at Admission Predict Severity and Mortality in COVID-19 Patients? A Systematic Review and Meta-analysis
    Amit Kumar, Prattay Guha Sarkar, Pragya Pant, J.I.T.H.I.N. KUMAR · 2022 · Indian Journal of Critical Care Medicine
  95. Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
    Marco Infante, Nathalia Padilla, Rodolfo Alejandro, Massimiliano Caprio, David Della‐Morte, Andrea Fabbri, Camillo Ricordi · 2022 · Medicina
  96. Endothelial GSDMD underlies LPS-induced systemic vascular injury and lethality
    Enyong Su, Xiaoyue Song, Lili S. Wei, Junqiang Xue, Xuelin Cheng, Shiyao Xie, Hong Xiang Jiang, Ming Liu · 2025 · JCI Insight
  97. Immunosuppressive dead cell as lung-targeting vehicle and cytokine absorption material for cytokine storm attenuation of pneumonia
    Tianyuan Ci, Yaoxuan Xiong, Jinniu Zhang, Jing Zang, Nianping Feng · 2023 · Materials Today Bio
  98. Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia
    Diana Cadena Castaneda, Sonia Jangra, Marina Yurieva, Jan Martínek, Megan Callender, Matthew A. Coxe, Angela Choi, Juan García-Bernalt Diego, Jianan Lin, Te-Chia Wu et al. · 2023 · iScience
  99. Advances in treatment strategies for COVID-19: Insights from other coronavirus diseases and prospects
    Yingwen Li, Jiaming Lan, Gary Wong · 2023 · Biosafety and Health
  100. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19
    Xiaoyun Cheng, Mao Jiang, Lingzhi Long, Jie Meng · 2021 · Frontiers in Bioscience-Landmark